Inducible recombination and gene expression in specific neurotransmitter systems

特定神经递质系统中的诱导重组和基因表达

• 批准号: 7778821
• 负责人: STEVEN A THOMAS
• 金额: $ 35.44万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-07-01 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7778821
• 关键词: 3' Untranslated Regions; Adrenergic Agents; Adult; Aftercare; Animal Model; Antibiotics; Anxiety; Arousal; Attention; Bacterial Artificial Chromosomes; Behavioral; Catecholamines; Chimeric Proteins; Cognitive; Communities; Complementary DNA; Development; Disease; Dopamine; Doxycycline; Drug abuse; Encephalomyocarditis virus; Enterobacteria phage P1 Cre recombinase; Enzymes; Epinephrine; Estrogen Receptors; Etiology; Gene Expression; Gene Targeting; Gene-Modified; Genes; Genetic Recombination; Genetic Transcription; Goals; High Pressure Liquid Chromatography; Immunofluorescence Immunologic; Internal Ribosome Entry Site; Learning; Ligand Binding Domain; Link; Location; Mediating; Memory; Mental Depression; Mental disorders; Mixed Function Oxygenases; Modification; Monitor; Motivation; Mus; Narcolepsy; Neurons; Neurosciences; Neurotransmitters; Norepinephrine; Pattern; Pharmaceutical Preparations; Physiological; Post-Traumatic Stress Disorders; Process; Proteins; Receptor Signaling; Reporter; Research; Research Personnel; Rewards; Role; Serotonin; Site; Sleep; Specific qualifier value; Stress; System; Tamoxifen; Tetanus Helper Peptide; Tetracyclines; Time; Trans-Activators; Transgenes; Transgenic Organisms; Tryptophan 5-monooxygenase; Tyrosine 3-Monooxygenase; adrenergic; base; dopamine system; dopamine transporter; dopaminergic neuron; embryonic stem cell; gene cloning; gene function; homologous recombination; hypocretin; insight; interest; mouse model; neurophysiology; norepinephrine system; programs; promoter; public health relevance; research study

DESCRIPTION (provided by investigator): The goal of this proposal is to advance our ability to inducibly manipulate gene expression within subsets of neurons. Four neurotransmitter systems have been chosen for this proposal based on their having been implicated in numerous neurophysiologic and behavioral processes, as well as disorders of those processes. The four are the adrenergic (norepinephrine and epinephrine), dopaminergic, serotonergic and orexinergic systems. Because of the unique ability to create gene-targeted mice among mammals, mice will be the model organism employed. One goal is to inducibly activate, inactivate or modify endogenous genes that have been endowed with unique loxP sites that are recognized by bacteriophage P1 Cre recombinase (Cre). The main approach for achieving this will be the neurotransmitter-specific expression of the tamoxifen-inducible Cre fusion protein, CreERT2, that is fused to a modified estrogen receptor ligand-binding domain (ERT2). Because there may be occasions when using tamoxifen should be avoided due to effects on endogenous estrogen receptor signaling, a second approach for achieving inducible Cre activity will also be pursued. For this approach, the tetracycline-inducible transactivator (tTA2) and reverse tTA (rtTA2S-M2) will be expressed specifically in each neurotransmitter system. When crossed with previously characterized tetO-Cre mice, the transactivator (TA) mice will induce the neurotransmitter-specific expression of Cre either in the absence (tTA) or in the presence (rtTA) of antibiotic. In addition, the TA mice will permit the induction of any other Ptet-cDNA transgene in a neurotransmitter-specific fashion. To obtain neurotransmitter-specific expression, genes that uniquely define these neurotransmitter systems will be utilized: for the adrenergic system - dopamine 2- hydroxylase, for the dopaminergic system - dopamine transporter, for the serotonergic system - tryptophan hydroxylase 2, and for the orexinergic system - orexin. CreERT2 and the TAs will be targeted to the 3'- untranslated region of each gene via homologous recombination in embryonic stem cells. To achieve bicistronic expression, CreERT2 and the TAs will be preceded by an internal ribosome entry site. Reporter mice for Cre activity will be used to correlate temporal and spatial expression patterns of Cre with those for the targeted endogenous gene. Finally, the utility of the CreERT2 and TA mice will be demonstrated by crossing them with mice harboring a floxed tyrosine hydroxylase gene for inducible transmitter depletion. PUBLIC HEALTH RELEVANCE The study of these four neurotransmitter systems via inducible changes in gene expression that are specific to each system is highly relevant to the understanding of fundamental neurophysiological and behavioral processes such as sleep, arousal and attention, motivation and reward, and learning and memory, as well as disorders related to these processes that include narcolepsy, drug abuse, anxiety, depression and post- traumatic stress disorder. It is expected that the proposed mouse models will permit significant insights into the etiology, identification and treatment of these disorders.

描述（由研究者提供）：本提案的目标是提高我们在神经元亚群内诱导操纵基因表达的能力。 四个神经递质系统已被选定为这个建议的基础上，他们已经牵连在许多神经生理和行为过程，以及这些过程的障碍。 这四种是肾上腺素能（去甲肾上腺素和肾上腺素）、多巴胺能、多巴胺能和食欲素能系统。 由于在哺乳动物中创造基因靶向小鼠的独特能力，小鼠将成为所采用的模型生物。 一个目标是诱导激活、修饰或修饰已被赋予被噬菌体P1 Cre重组酶（Cre）识别的独特loxP位点的内源基因。 实现这一目标的主要方法将是他莫昔芬诱导的Cre融合蛋白CreERT 2的神经递质特异性表达，CreERT 2与修饰的雌激素受体配体结合结构域（ERT 2）融合。 由于可能存在由于对内源性雌激素受体信号传导的影响而应避免使用他莫昔芬的情况，因此还将追求实现诱导型Cre活性的第二种方法。 对于这种方法，四环素诱导的反式激活因子（tTA 2）和反向tTA（rtTA 2S-M2）将在每个神经递质系统中特异性表达。 当与先前表征的tetO-Cre小鼠杂交时，反式激活因子（TA）小鼠将在抗生素不存在（tTA）或存在（rtTA）的情况下诱导Cre的神经递质特异性表达。 此外，TA小鼠将允许以神经递质特异性方式诱导任何其他Ptet-cDNA转基因。 为了获得神经递质特异性表达，将利用独特定义这些神经递质系统的基因：肾上腺素能系统-多巴胺2-羟化酶，多巴胺能系统-多巴胺转运蛋白，多巴胺能系统-色氨酸羟化酶2，以及食欲素能系统-食欲素。 CreERT 2和TA将通过胚胎干细胞中的同源重组靶向每个基因的3 '非翻译区。 为了实现双顺反子表达，CreERT 2和TA将在内部核糖体进入位点之前。 Cre活性的报告小鼠将用于将Cre的时间和空间表达模式与靶向内源基因的表达模式相关联。 最后，CreERT 2和TA小鼠的效用将通过将它们与携带floxed酪氨酸羟化酶基因的小鼠杂交来证明，用于诱导性递质耗竭。 公共卫生相关性通过基因表达的诱导性变化对这四种神经递质系统进行研究，这些基因表达对每个系统都是特异性的，这与理解基本的神经生理学和行为过程高度相关，如睡眠、唤醒和注意力、动机和奖励、学习和记忆，以及与这些过程相关的疾病，包括嗜睡症、药物滥用、焦虑、抑郁症和创伤后应激障碍。 预计提出的小鼠模型将允许对这些疾病的病因学、鉴定和治疗有重要的见解。